Pheiron

Curated by Signal

Developer of a phenotyping platform that decodes disease to advance new therapies

Overview

Developer of a phenotyping platform that decodes disease to advance new therapies. The company leverages AI and biomedical data to generate digital biomarkers and integrates multi-omics data to redefine how diseases are understood and treated.

Key facts

Founded: 2023
Headquarters: Berlin, Germany
Stage: Sign up to view
Industry: Health Technology

Business model

8 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

FIRST AID GP
Provider of medical adherence emergency response app for cardiac health
Health TechnologyGoppingen, Germany
Sanoliste
Provider of an online directory focused on the healthcare sector
Health TechnologyCologne, Germany
IQM
Provider of quality management software for healthcare providers
Health TechnologyHamburg, Germany

About Pheiron

What does Pheiron do?

Developer of a phenotyping platform that decodes disease to advance new therapies.

Where is Pheiron headquartered?

Pheiron is headquartered in Berlin, Germany.

When was Pheiron founded?

Pheiron was founded in 2023.

Which sector is Pheiron in?

Pheiron operates in Health Technology.

Who are Pheiron's competitors?

Companies similar to Pheiron include FIRST AID GP, Sanoliste, and IQM.